Compare Medpace Holdings Inc (MEDP) vs Realty Income Corp (O) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Realty Income Corp — how do they compare? Medpace Holdings Inc trades at $607 (market cap $16.90B), while Realty Income Corp trades at $61.85 (market cap $58.56B). The key difference: Realty Income Corp is far larger — about 3.5× Medpace Holdings Inc's market cap, and Realty Income Corp pays a 5.25% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | O | |
|---|---|---|
Market Cap | $16.90B | $58.56B |
Sector | Technology | Real Estate |
52-Week High | $620.59 | $67.56 |
52-Week Low | $393.42 | $55.93 |
Enterprise Value | $16.52B | $89.19B |
Dividend Yield | — | 5.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Realty Income (O) trades at $61.89, down 0.99% for the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported Q2 2026 EPS of $0.37, missing the $0.3977 estimate, but raised full-year AFFO guidance. Recent news highlights a $875 million convertible notes offering and a $6 billion hyperscale data center joint venture, supporting growth initiatives amid a 98.8% portfolio occupancy rate.
Outlook remains supported by dividend growth—115 consecutive quarterly increases—and a $10 billion investment target, though elevated debt levels and interest rate sensitivity pose risks. Analysts maintain a consensus price target of $67.29, implying ~9% upside, with 41% buy ratings reflecting cautious optimism for the REIT's income stability and expansion into data centers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Realty Income Corp
Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.
Read more on O →
